Viatris acquires two companies for $750 million to sharpen ophthalmology vision
Viatris acquires two companies for $750 million to fuel ophthalmology vision
Drugs
Health
Pharma
Drugs
Pharma
Cipla’s board rejects plan to transfer US-based operations
HQ Team November 4, 2022: The management of Cipla, an Indian drug maker, has rejected a plan to transfer its US-based operations based.
Drugs
Pharma
Pfizer, BioNTech start trial on one vaccine to prevent both Covid-19, influenza
HQ Team November 4, 2022: The US-based drugmaker Pfizer Inc and Germany’s BioNTech have started clinical trials for a vaccine to prevent both.
Drugs
Pharma
Diabetes, obesity drugs boost Novo Nordisk profit, sales
Novo Nordisk net profit rose 14% year-on-year in nine months to September as it forecasted higher profit and sales for the year on.
Drugs
Pharma
Two Indian firms get FDA nod for drugs to treat ulcerative colitis, fight ammonia
HQ Team November 2, 2022: Two public Indian pharmaceutical companies have received USFDA approvals for selling drugs meant to treat ulcerative colitis and.
Drugs
Pharma
Eli Lilly grants $50 mn for Purdue University research
HQ Team November 2, 2022: Eli Lilly and Company and Purdue University will create a new pharmaceutical manufacturing scholarship program and have renewed.
Drugs
Pharma
Verge Genomics starts human trials with AI drug
Verge Genomics, backed by Eli Lilly and Merck & Co., announced it had dosed a human during clinical trials with a drug discovered.
Drugs
Health
Anti-depressants can rewire brain structure
Anti-depressants can change brain structure and improve mental health.
Drugs
Pharma
EMA cracks the whip on JAK inhibitors for inflammatory disorders
The European Medicines Agency has suggested steps to minimize the risk of severe side effects associated with Janus kinase (JAK) inhibitors, used to.